Skip to main content

Table 5 Reports of resource utilization in bleeding patients with IMC

From: Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety

Category

Count

%

Extended LOS

18

100.0%

FFP

12

66.7%

RBC

10

55.6%

Vit K

10

55.6%

Steroids

8

44.4%

PLT

8

44.4%

IVIG

7

38.9%

Plasmapheresis

5

27.8%

Chemotherapy

3

16.7%

  1. LOS – Length of stay; FFP – fresh frozen plasma; Vit K – vitamin K; IVIG – intravenous immune globulin; PLT – platelets; RBC – red blood cells
  2. Interventions among the 18 bleeding patients for whom case reports contained documentation of managing immune-mediated coagulopathy [6, 7, 9, 10, 15–17, 20, 23, 26, 27, 30, 31, 33, 34].
Back to article page

Patient Safety in Surgery

ISSN: 1754-9493